US4441441098 - Common Stock

Taking everything into account, **HDSN** scores **6** out of 10 in our fundamental rating. **HDSN** was compared to 52 industry peers in the **Trading Companies & Distributors** industry. **HDSN** has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. **HDSN** is not valued too expensively and it also shows a decent growth rate.

In the past year **HDSN** was profitable.

In multiple years **HDSN** reported negative net income over the last 5 years.

The **Return On Assets** of **HDSN** (**18.33%**) is better than **96.08%** of its industry peers.

The **Return On Equity** of **HDSN** (**23.78%**) is better than **74.51%** of its industry peers.

Measured over the past 3 years, the **Average Return On Invested Capital** for **HDSN** is significantly above the industry average of **11.10%**.

The 3 year average ROIC (**23.70%**) for **HDSN** is below the current ROIC(**27.18%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 18.33% | ||

ROE | 23.78% | ||

ROIC | 27.18% |

ROA(3y)16.62%

ROA(5y)2.22%

ROE(3y)30.7%

ROE(5y)-9.16%

ROIC(3y)23.7%

ROIC(5y)N/A

The **Operating Margin** of **HDSN** (**27.64%**) is better than **80.39%** of its industry peers.

The **Gross Margin** of **HDSN** (**38.68%**) is better than **62.75%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 27.64% | ||

PM (TTM) | 18.31% | ||

GM | 38.68% |

OM growth 3YN/A

OM growth 5Y30.33%

PM growth 3YN/A

PM growth 5Y31.96%

GM growth 3Y67.75%

GM growth 5Y13.1%

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), **HDSN** is creating value.

The number of shares outstanding for **HDSN** has been increased compared to 1 year ago.

The number of shares outstanding for **HDSN** has been increased compared to 5 years ago.

Compared to 1 year ago, **HDSN** has an improved debt to assets ratio.

With an excellent **Altman-Z score** value of **8.96**, **HDSN** belongs to the best of the industry, outperforming **94.12%** of the companies in the same industry.

There is no outstanding debt for **HDSN**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0.12 | ||

Altman-Z | 8.96 |

ROIC/WACC2.85

WACC9.53%

A Current Ratio of **3.47** indicates that **HDSN** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.47 | ||

Quick Ratio | 1.03 |

The earnings per share for **HDSN** have decreased strongly by **-46.40%** in the last year.

The **Earnings Per Share** has been growing by **52.13%** on average over the past years. This is a very strong growth

The **Revenue** has decreased by **-7.58%** in the past year.

The **Revenue** has been growing by **18.29%** on average over the past years. This is quite good.

EPS 1Y (TTM)-46.4%

EPS 3YN/A

EPS 5Y52.13%

EPS growth Q2Q-45.16%

Revenue 1Y (TTM)-7.58%

Revenue growth 3Y26.12%

Revenue growth 5Y18.29%

Revenue growth Q2Q-14.53%

Based on estimates for the next years, **HDSN** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-9.85%** on average per year.

The **Revenue** is expected to grow by **8.05%** on average over the next years. This is quite good.

EPS Next Y-47.38%

EPS Next 2Y-22.22%

EPS Next 3Y-9.85%

EPS Next 5YN/A

Revenue Next Year-9.75%

Revenue Next 2Y1.1%

Revenue Next 3Y8.05%

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

Based on the **Price/Earnings** ratio of **12.41**, the valuation of **HDSN** can be described as correct.

Based on the **Price/Earnings** ratio, **HDSN** is valued a bit cheaper than 64.71% of the companies in the same industry.

Based on the **Price/Forward Earnings** ratio of **11.10**, the valuation of **HDSN** can be described as reasonable.

74.51% of the companies in the same industry are more expensive than **HDSN**, based on the **Price/Forward Earnings** ratio.

When comparing the **Price/Forward Earnings** ratio of **HDSN** to the average of the S&P500 Index (**21.63**), we can say **HDSN** is valued slightly cheaper.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 12.41 | ||

Fwd PE | 11.1 |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **HDSN** indicates a somewhat cheap valuation: **HDSN** is cheaper than 68.63% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 15.94 | ||

EV/EBITDA | 7.7 |

The excellent profitability rating of **HDSN** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.24

EPS Next 2Y-22.22%

EPS Next 3Y-9.85%

No dividends for **HDSN**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**HUDSON TECHNOLOGIES INC**

NASDAQ:HDSN (2/23/2024, 7:00:01 PM)

After market: 14.77 0 (0%)**14.77**

**+0.19 (+1.3%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryTrading Companies & Distributors

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap672.03M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 12.41 | ||

Fwd PE | 11.1 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.24

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 18.33% | ||

ROE | 23.78% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 27.64% | ||

PM (TTM) | 18.31% | ||

GM | 38.68% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 3.47 | ||

Quick Ratio | 1.03 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-46.4%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-47.38%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-7.58%

Revenue growth 3Y26.12%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y